B.Riley Financial Maintains Veru Inc(VERU.US) With Buy Rating, Maintains Target Price $5

Futu News12:33 · Ratings

Dow Edges Higher; AT&T Posts Upbeat Earnings

Benzinga01:05

Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough

BenzingaJan 27 23:34

Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December

BenzingaJan 27 22:43

Veru Down 46% Despite Data for Drug Preserving Lean Body Mass in Wegovy Users

Seeking AlphaJan 27 22:35

Express News | Veru: Enobosarm Cut Proportion of Patients That Lost Clinically Significant Physical Function Vs Those on Wegovy Alone

BreakingsJan 27 19:33